HRH1 and obesity due to melanocortin 4 receptor deficiency: Unsatisfactorily, though proved to be involved in feeding, a number of H1Rs-related drugs failed to have the anti-obesity effects clinically, probably because they would activate peripheral H1R sites that could lead to severe cardiovascular, respiratory, or gastrointestinal side effects in the drug delivery process to the CNS [32].